Controversies and Advances With Testosterone Therapy: A 40-Year Perspective - 12/03/16
Abstract |
Testosterone therapy (TTh) has become highly controversial. There are important health consequences of testosterone deficiency, and meaningful benefits with treatment. There is level 1 evidence that TTh improves sexual function and desire, body composition, and bone density. Concerns regarding cardiovascular risk were based on two deeply flawed retrospective studies and are contradicted by dozens of studies showing cardiovascular benefits of TTh or higher endogenous testosterone, including placebo-controlled studies in men with known heart disease (angina, heart failure). Prostate cancer should no longer be considered a risk of TTh. Testosterone is neither scourge nor panacea—it is just good medicine.
Le texte complet de cet article est disponible en PDF.Plan
| Financial Disclosure: Abraham Morgentaler, M.D., has received payments for consulting, scientific advisory boards, research grants, or lecture honoraria from AbbVie, Bayer, Clarus, Endo, Eli Lilly, and Pfizer. |
Vol 89
P. 27-32 - mars 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?

